Releases
New Data Reveals DCT Components Linked to Improvements in Clinical Trial Access Among Underrepresented Communities
Medable's groundbreaking study with the Tufts PACT Consortium highlights the transformative impact of decentralized clinical trials (DCTs) on diversity.
Medable Reports 80% Revenue Growth from Portfolio-Level eCOA Adoption, Sharp Increase Compared to Study-by-Study Adoption
Medable reports 80% revenue growth from portfolio-level eCOA adoption in 2024, reflecting growing confidence in scalable digital solutions for clinical trials.
New Medable AI Capabilities Simplify Digital Clinical Trial Launch with Instant eCOA Generation
Medable Studio is the first solution to leverage generative AI to reduce eCOA build times to seconds.
Medable Joins Forces with Google Cloud to Deliver Digital Clinical Trials Technology on Google Cloud Marketplace
Medable, a leading provider of clinical development technology, today announced a collaboration with Google Cloud to bring Medable’s Digital andDecentralized Clinical Trial Platform to Google Cloud Marketplace.
-sm.jpg)
Medable Named Top Patient Engagement Trailblazer by Everest Group
Clinical research industry’s largest, most diverse global network of patient advocates improves the trial experience across therapeutic areas and technologies
New Medable Studio Empowers Sponsors to Launch eCOA Solutions into Clinical Trials with Unparalleled Control and Efficiency
Medable Studio for eCOA nowavailable; two top-10 pharma company early adopters
Medable Wins 2024 Prix Galien UK Award for Best Digital Health Solution
Medable today announced that its evidence generation platform was awarded “Best Digital Health Solution” from a field of 17 nominees at the Prix Galien UK Forum in London. This marks the second time Medable has won the Best Digital Health Solution award, first taking home the honor in 2023 at the Prix Galien US ceremony.
.jpg)
New Research from Partnership for Advancing Clinical Trials (PACT) Reveals Decentralized Clinical Trials (DCTs) Beat Timeline Expectations
Medable today announced that the Partnership for Advancing Clinical Trials (PACT) consortium in conjunction with the Tufts Center for the Study of Drug Development (CSDD) has produced compelling results from a new study.
Medable and Masimo Partner to Bring Best-in-Class Wearable Devices to Clinical Research, Capturing Rich Subjective and Objective Data
Medable is partnering with industry leader Masimo to bring best-in-class medical-grade wearable devices to clinical research.
Medable Achieves 75% eConsent Adoption Across Elderly Patients in Pivotal U.S. Renal Care Clinical Trial
The Phase IV trial, funded by a top-10 global pharmaceutical company, had a narrow recruitment window to enroll patients suffering from Anemia in End Stage Kidney Disease (ESKD) across more than 40 dialysis centers, involving 476 site users.
Medable Partners with Duke BASE Lab to Study Patient Preference of Electronic Informed Consent in Clinical Trials
Medable announces results from a new research project with Duke University BASE Lab on enhanced electronic informed consent (eIC) in clinical trials.
Medable to Present at 42nd Annual J.P. Morgan Healthcare Conference
Medable CEO and Co-Founder Michelle Longmire will be presenting a corporate update at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco.
Medable Wins 2023 Prix Galien Award for Best Digital Health Solution
Medable was awarded ‘Best Digital Health Solution’ from a field of 24 nominees at the Prix Galien USA Forum in New York City. This recognition underscores the impact of Medable’s evidence generation platform on clinical research worldwide.